CD8A and central nervous system cancer: In line with this reasoning, CD8+ TILs from pTRT cell-high BrM showed a significantly higher enrichment of multiple neoantigen-reactive CD8+ T cell gene signatures than pTRT cell-low BrM or glioma (Fig. 2f).